Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor (Q37022647)

From Wikidata

Revision as of 14:01, 13 May 2024 by Emijrpbot (talk | contribs) (‎Changed label, description and/or aliases in fr, pt, da: BOT - Fixing descriptions (3 languages): da, fr, pt)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on 11 March 2016

Language	Label	Description	Also known as
English	Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor	scientific article published on 11 March 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Lei Zhang

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

David Shimizu

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Jeffrey L Killeen

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Stacey A Honda

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Di Lu

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Alexander Stanoyevitch

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Fritz Lin

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Beverly Wang

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Edwin S Monuki

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Michele Carbone

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

0 references

publication date

11 March 2016

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Human Pathology

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

53

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

159-167

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

High-grade endometrial carcinomas - strategies for typing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Endometrial cancer invasion depends on cancer-derived tumor necrosis factor-alpha and stromal derived hepatocyte growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Prognostic features of surgical stage I uterine carcinosarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

HB-EGF is a potent inducer of tumor growth and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Distribution of integrin cell adhesion molecules in endometrial cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Morphologic prognostic factors of malignant mixed müllerian tumor of the uterus: a clinicopathologic study of 58 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

29 September 2017

Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

27 June 2018

Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

4 September 2018

EGFR signaling patterns are regulated by its different ligands.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

4 September 2018

HB-EGF promotes intestinal restitution by affecting integrin-extracellular matrix interactions and intercellular adhesions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

4 September 2018

EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

4 September 2018

Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4914425

4 September 2018

Overexpression of the alphavbeta6 integrin in endometrial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26980026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26980026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26980026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26980026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different expression patterns of KIT, EGFR, and HER‐2 (c‐erbB‐2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26980026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.HUMPATH.2016.02.014

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37022647&oldid=2153186670"